vimarsana.com
Home
Live Updates
US FDA Declines to Approve Viatris's Injection for Multiple Sclerosis : vimarsana.com
US FDA Declines to Approve Viatris's Injection for Multiple Sclerosis : vimarsana.com
US FDA Declines to Approve Viatris's Injection for Multiple Sclerosis
The U.S. FDA has declined to approve Viatris and Mapi Pharma's once-a-month injection for treating relapsing forms of debilitating neurological condition multiple sclerosis...
Related Keywords
Bengaluru ,
Karnataka ,
India ,
United States ,
Pooja Desai ,
Shinjini Ganguli ,
Sriparna Roy ,
Mapi Pharma ,
Reuters ,
National Institutes Of Health ,
Teva Pharmaceutical Industrie ,
National Institutes ,
Multiple Sclerosis Ms ,
S Multiple Sclerosis ,
Glatiramer Acetate ,
Brain ,
Disability ,
Biologic Therapy ,
Iologics ,
Practice Management ,
Evenue ,